Rillide

Rillide was founded in 2024 by Dr. Wei Long, former Executive Vice President of Jacobio Pharmaceuticals and a seasoned drug development expert. The company focuses on developing innovative oral medications for patients with autoimmune diseases by deeply integrating artificial intelligence technology with industry expert practices, leveraging AI-driven molecular discovery for industrial applications to provide better and safer treatment options.